Report Cover

Global and United States Remicade (infliximab) Drug Market Insights, Forecast to 2026


Remicade (infliximab) Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Remicade (infliximab) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Remicade (infliximab) Drug market is segmented into
    Brands Drugs
    Generic Drugs

Segment by Application, the Remicade (infliximab) Drug market is segmented into
    Crohn's Disease
    Pediatric Crohn's Disease
    Ulcerative Colitis
    Pediatric Ulcerative Colitis
    Other

Regional and Country-level Analysis
The Remicade (infliximab) Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Remicade (infliximab) Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Remicade (infliximab) Drug Market Share Analysis
Remicade (infliximab) Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Remicade (infliximab) Drug business, the date to enter into the Remicade (infliximab) Drug market, Remicade (infliximab) Drug product introduction, recent developments, etc.
The major vendors covered:
    Janssen
    Hospira
    Celltrion Healthcare
    Epirus Biopharmaceuticals
    Samsung Bioepsis
    ...
1 Study Coverage
    1.1 Remicade (infliximab) Drug Product Introduction
    1.2 Market Segments
    1.3 Key Remicade (infliximab) Drug Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Remicade (infliximab) Drug Market Size Growth Rate by Type
        1.4.2 Brands Drugs
        1.4.3 Generic Drugs
    1.5 Market by Application
        1.5.1 Global Remicade (infliximab) Drug Market Size Growth Rate by Application
        1.5.2 Crohn's Disease
        1.5.3 Pediatric Crohn's Disease
        1.5.4 Ulcerative Colitis
        1.5.5 Pediatric Ulcerative Colitis
        1.5.6 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Remicade (infliximab) Drug Market Size, Estimates and Forecasts
        2.1.1 Global Remicade (infliximab) Drug Revenue 2015-2026
        2.1.2 Global Remicade (infliximab) Drug Sales 2015-2026
    2.2 Global Remicade (infliximab) Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    2.3 Remicade (infliximab) Drug Historical Market Size by Region (2015-2020)
        2.3.1 Global Remicade (infliximab) Drug Retrospective Market Scenario in Sales by Region: 2015-2020
        2.3.2 Global Remicade (infliximab) Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
    2.4 Remicade (infliximab) Drug Market Estimates and Projections by Region (2021-2026)
        2.4.1 Global Remicade (infliximab) Drug Sales Forecast by Region (2021-2026)
        2.4.2 Global Remicade (infliximab) Drug Revenue Forecast by Region (2021-2026)

3 Global Remicade (infliximab) Drug Competitor Landscape by Players
    3.1 Global Top Remicade (infliximab) Drug Sales by Manufacturers
        3.1.1 Global Remicade (infliximab) Drug Sales by Manufacturers (2015-2020)
        3.1.2 Global Remicade (infliximab) Drug Sales Market Share by Manufacturers (2015-2020)
    3.2 Global Remicade (infliximab) Drug Manufacturers by Revenue
        3.2.1 Global Remicade (infliximab) Drug Revenue by Manufacturers (2015-2020)
        3.2.2 Global Remicade (infliximab) Drug Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Remicade (infliximab) Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Remicade (infliximab) Drug Revenue in 2019
        3.2.5 Global Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Remicade (infliximab) Drug Price by Manufacturers
    3.4 Global Remicade (infliximab) Drug Manufacturing Base Distribution, Product Types
        3.4.1 Remicade (infliximab) Drug Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Remicade (infliximab) Drug Product Type
        3.4.3 Date of International Manufacturers Enter into Remicade (infliximab) Drug Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Remicade (infliximab) Drug Market Size by Type (2015-2020)
        4.1.1 Global Remicade (infliximab) Drug Sales by Type (2015-2020)
        4.1.2 Global Remicade (infliximab) Drug Revenue by Type (2015-2020)
        4.1.3 Remicade (infliximab) Drug Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Remicade (infliximab) Drug Market Size Forecast by Type (2021-2026)
        4.2.1 Global Remicade (infliximab) Drug Sales Forecast by Type (2021-2026)
        4.2.2 Global Remicade (infliximab) Drug Revenue Forecast by Type (2021-2026)
        4.2.3 Remicade (infliximab) Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Remicade (infliximab) Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Remicade (infliximab) Drug Market Size by Application (2015-2020)
        5.1.1 Global Remicade (infliximab) Drug Sales by Application (2015-2020)
        5.1.2 Global Remicade (infliximab) Drug Revenue by Application (2015-2020)
        5.1.3 Remicade (infliximab) Drug Price by Application (2015-2020)
    5.2 Remicade (infliximab) Drug Market Size Forecast by Application (2021-2026)
        5.2.1 Global Remicade (infliximab) Drug Sales Forecast by Application (2021-2026)
        5.2.2 Global Remicade (infliximab) Drug Revenue Forecast by Application (2021-2026)
        5.2.3 Global Remicade (infliximab) Drug Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
    6.1 United States Remicade (infliximab) Drug Market Size YoY Growth 2015-2026
        6.1.1 United States Remicade (infliximab) Drug Sales YoY Growth 2015-2026
        6.1.2 United States Remicade (infliximab) Drug Revenue YoY Growth 2015-2026
        6.1.3 United States Remicade (infliximab) Drug Market Share in Global Market 2015-2026
    6.2 United States Remicade (infliximab) Drug Market Size by Players (International and Local Players)
        6.2.1 United States Top Remicade (infliximab) Drug Players by Sales (2015-2020)
        6.2.2 United States Top Remicade (infliximab) Drug Players by Revenue (2015-2020)
    6.3 United States Remicade (infliximab) Drug Historic Market Review by Type (2015-2020)
        6.3.1 United States Remicade (infliximab) Drug Sales Market Share by Type (2015-2020)
        6.3.2 United States Remicade (infliximab) Drug Revenue Market Share by Type (2015-2020)
        6.3.3 United States Remicade (infliximab) Drug Price by Type (2015-2020)
    6.4 United States Remicade (infliximab) Drug Market Estimates and Forecasts by Type (2021-2026)
        6.4.1 United States Remicade (infliximab) Drug Sales Forecast by Type (2021-2026)
        6.4.2 United States Remicade (infliximab) Drug Revenue Forecast by Type (2021-2026)
        6.4.3 United States Remicade (infliximab) Drug Price Forecast by Type (2021-2026)
    6.5 United States Remicade (infliximab) Drug Historic Market Review by Application (2015-2020)
        6.5.1 United States Remicade (infliximab) Drug Sales Market Share by Application (2015-2020)
        6.5.2 United States Remicade (infliximab) Drug Revenue Market Share by Application (2015-2020)
        6.5.3 United States Remicade (infliximab) Drug Price by Application (2015-2020)
    6.6 United States Remicade (infliximab) Drug Market Estimates and Forecasts by Application (2021-2026)
        6.6.1 United States Remicade (infliximab) Drug Sales Forecast by Application (2021-2026)
        6.6.2 United States Remicade (infliximab) Drug Revenue Forecast by Application (2021-2026)
        6.6.3 United States Remicade (infliximab) Drug Price Forecast by Application (2021-2026)

7 North America
    7.1 North America Remicade (infliximab) Drug Market Size YoY Growth 2015-2026
    7.2 North America Remicade (infliximab) Drug Market Facts & Figures by Country
        7.2.1 North America Remicade (infliximab) Drug Sales by Country (2015-2020)
        7.2.2 North America Remicade (infliximab) Drug Revenue by Country (2015-2020)
        7.2.3 U.S.
        7.2.4 Canada

8 Europe
    8.1 Europe Remicade (infliximab) Drug Market Size YoY Growth 2015-2026
    8.2 Europe Remicade (infliximab) Drug Market Facts & Figures by Country
        8.2.1 Europe Remicade (infliximab) Drug Sales by Country
        8.2.2 Europe Remicade (infliximab) Drug Revenue by Country
        8.2.3 Germany
        8.2.4 France
        8.2.5 U.K.
        8.2.6 Italy
        8.2.7 Russia

9 Asia Pacific
    9.1 Asia Pacific Remicade (infliximab) Drug Market Size YoY Growth 2015-2026
    9.2 Asia Pacific Remicade (infliximab) Drug Market Facts & Figures by Country
        9.2.1 Asia Pacific Remicade (infliximab) Drug Sales by Region (2015-2020)
        9.2.2 Asia Pacific Remicade (infliximab) Drug Revenue by Region
        9.2.3 China
        9.2.4 Japan
        9.2.5 South Korea
        9.2.6 India
        9.2.7 Australia
        9.2.8 Taiwan
        9.2.9 Indonesia
        9.2.10 Thailand
        9.2.11 Malaysia
        9.2.12 Philippines
        9.2.13 Vietnam

10 Latin America
    10.1 Latin America Remicade (infliximab) Drug Market Size YoY Growth 2015-2026
    10.2 Latin America Remicade (infliximab) Drug Market Facts & Figures by Country
        10.2.1 Latin America Remicade (infliximab) Drug Sales by Country
        10.2.2 Latin America Remicade (infliximab) Drug Revenue by Country
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Remicade (infliximab) Drug Market Size YoY Growth 2015-2026
    11.2 Middle East and Africa Remicade (infliximab) Drug Market Facts & Figures by Country
        11.2.1 Middle East and Africa Remicade (infliximab) Drug Sales by Country
        11.2.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Country
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 Janssen
        12.1.1 Janssen Corporation Information
        12.1.2 Janssen Description and Business Overview
        12.1.3 Janssen Sales, Revenue and Gross Margin (2015-2020)
        12.1.4 Janssen Remicade (infliximab) Drug Products Offered
        12.1.5 Janssen Recent Development
    12.2 Hospira
        12.2.1 Hospira Corporation Information
        12.2.2 Hospira Description and Business Overview
        12.2.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
        12.2.4 Hospira Remicade (infliximab) Drug Products Offered
        12.2.5 Hospira Recent Development
    12.3 Celltrion Healthcare
        12.3.1 Celltrion Healthcare Corporation Information
        12.3.2 Celltrion Healthcare Description and Business Overview
        12.3.3 Celltrion Healthcare Sales, Revenue and Gross Margin (2015-2020)
        12.3.4 Celltrion Healthcare Remicade (infliximab) Drug Products Offered
        12.3.5 Celltrion Healthcare Recent Development
    12.4 Epirus Biopharmaceuticals
        12.4.1 Epirus Biopharmaceuticals Corporation Information
        12.4.2 Epirus Biopharmaceuticals Description and Business Overview
        12.4.3 Epirus Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
        12.4.4 Epirus Biopharmaceuticals Remicade (infliximab) Drug Products Offered
        12.4.5 Epirus Biopharmaceuticals Recent Development
    12.5 Samsung Bioepsis
        12.5.1 Samsung Bioepsis Corporation Information
        12.5.2 Samsung Bioepsis Description and Business Overview
        12.5.3 Samsung Bioepsis Sales, Revenue and Gross Margin (2015-2020)
        12.5.4 Samsung Bioepsis Remicade (infliximab) Drug Products Offered
        12.5.5 Samsung Bioepsis Recent Development
    12.11 Janssen
        12.11.1 Janssen Corporation Information
        12.11.2 Janssen Description and Business Overview
        12.11.3 Janssen Sales, Revenue and Gross Margin (2015-2020)
        12.11.4 Janssen Remicade (infliximab) Drug Products Offered
        12.11.5 Janssen Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Remicade (infliximab) Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Remicade (infliximab) Drug Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Remicade (infliximab) Drug Market Segments Table 2. Ranking of Global Top Remicade (infliximab) Drug Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Remicade (infliximab) Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Brands Drugs Table 5. Major Manufacturers of Generic Drugs Table 6. Global Remicade (infliximab) Drug Market Size Growth Rate by Application 2020-2026 (K Units) Table 7. Global Remicade (infliximab) Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 8. Global Remicade (infliximab) Drug Sales by Regions 2015-2020 (K Units) Table 9. Global Remicade (infliximab) Drug Sales Market Share by Regions (2015-2020) Table 10. Global Remicade (infliximab) Drug Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Remicade (infliximab) Drug Sales Forecast by Region (2021-2026) (K Units) Table 12. Global Remicade (infliximab) Drug Sales by Manufacturers (2015-2020) (K Units) Table 13. Global Remicade (infliximab) Drug Sales Share by Manufacturers (2015-2020) Table 14. Global Remicade (infliximab) Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 15. Global Remicade (infliximab) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Remicade (infliximab) Drug as of 2019) Table 16. Remicade (infliximab) Drug Revenue by Manufacturers (2015-2020) (US$ Million) Table 17. Remicade (infliximab) Drug Revenue Share by Manufacturers (2015-2020) Table 18. Key Manufacturers Remicade (infliximab) Drug Price (2015-2020) (USD/Unit) Table 19. Remicade (infliximab) Drug Manufacturers Manufacturing Base Distribution and Headquarters Table 20. Manufacturers Remicade (infliximab) Drug Product Type Table 21. Date of International Manufacturers Enter into Remicade (infliximab) Drug Market Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans Table 23. Global Remicade (infliximab) Drug Sales by Type (2015-2020) (K Units) Table 24. Global Remicade (infliximab) Drug Sales Share by Type (2015-2020) Table 25. Global Remicade (infliximab) Drug Revenue by Type (2015-2020) (US$ Million) Table 26. Global Remicade (infliximab) Drug Revenue Share by Type (2015-2020) Table 27. Remicade (infliximab) Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 28. Global Remicade (infliximab) Drug Sales Share by Type (2021-2026) Table 29. Global Remicade (infliximab) Drug Sales by Application (2015-2020) (K Units) Table 30. Global Remicade (infliximab) Drug Sales Share by Application (2015-2020) Table 31. Global Remicade (infliximab) Drug Sales Share by Application (2021-2026) Table 32. Global Remicade (infliximab) Drug Sales Market Share Forecast by Application (2021-2026) Table 33. Global Remicade (infliximab) Drug Revenue by Application (2015-2020) (US$ Million) Table 34. Global Remicade (infliximab) Drug Revenue Market Share Forecast by Application (2021-2026) Table 35. United States Remicade (infliximab) Drug Sales (K Units) of Key Companies (2015-2020) Table 36. United States Remicade (infliximab) Drug Sales Share by Company (2015-2020) Table 37. United States Remicade (infliximab) Drug Revenue (US$ Million) by Company (2015-2020) Table 38. United States Remicade (infliximab) Drug Sales (K Units) by Type (2015-2020) Table 39. United States Remicade (infliximab) Drug Sales Share by Type (2015-2020) Table 40. United States Remicade (infliximab) Drug Revenue (US$ Million) Market Share by Type (2015-2020) Table 41. United States Remicade (infliximab) Drug Price (K Units) by Type (2015-2020) Table 42. United States Remicade (infliximab) Drug Sales (K Units) by Type (2021-2026) Table 43. United States Remicade (infliximab) Drug Sales Share by Type (2021-2026) Table 44. United States Remicade (infliximab) Drug Revenue (US$ Million) Market Share by Type (2021-2026) Table 45. United States Remicade (infliximab) Drug Revenue Share by Type (2021-2026) Table 46. United States Remicade (infliximab) Drug Price (K Units) by Type (2021-2026) Table 47. United States Remicade (infliximab) Drug Sales (K Units) by Application (2015-2020) Table 48. United States Remicade (infliximab) Drug Sales Share by Application (2015-2020) Table 49. United States Remicade (infliximab) Drug Revenue (US$ Million) Market Share by Application (2015-2020) Table 50. United States Remicade (infliximab) Drug Sales (K Units) by Application (2021-2026) Table 51. United States Remicade (infliximab) Drug Sales Share by Application (2021-2026) Table 52. United States Remicade (infliximab) Drug Revenue (US$ Million) Market Share by Application (2021-2026) Table 53. United States Remicade (infliximab) Drug Revenue Share by Application (2021-2026) Table 54. North America Remicade (infliximab) Drug Sales by Country (2015-2020) (K Units) Table 55. North America Remicade (infliximab) Drug Sales Market Share by Country (2015-2020) Table 56. North America Remicade (infliximab) Drug Revenue by Country (2015-2020) (US$ Million) Table 57. North America Remicade (infliximab) Drug Revenue Market Share by Country (2015-2020) Table 58. Europe Remicade (infliximab) Drug Sales by Country (2015-2020) (K Units) Table 59. Europe Remicade (infliximab) Drug Sales Market Share by Country (2015-2020) Table 60. Europe Remicade (infliximab) Drug Revenue by Country (2015-2020) (US$ Million) Table 61. Europe Remicade (infliximab) Drug Revenue Market Share by Country (2015-2020) Table 62. Asia Pacific Remicade (infliximab) Drug Sales by Region (2015-2020) (K Units) Table 63. Asia Pacific Remicade (infliximab) Drug Sales Market Share by Region (2015-2020) Table 64. Asia Pacific Remicade (infliximab) Drug Revenue by Region (2015-2020) (US$ Million) Table 65. Asia Pacific Remicade (infliximab) Drug Revenue Market Share by Region (2015-2020) Table 66. Latin America Remicade (infliximab) Drug Sales by Country (2015-2020) (K Units) Table 67. Latin America Remicade (infliximab) Drug Sales Market Share by Country (2015-2020) Table 68. Latin Americaa Remicade (infliximab) Drug Revenue by Country (2015-2020) (US$ Million) Table 69. Latin America Remicade (infliximab) Drug Revenue Market Share by Country (2015-2020) Table 70. Middle East and Africa Remicade (infliximab) Drug Sales by Country (2015-2020) (K Units) Table 71. Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Country (2015-2020) Table 72. Middle East and Africa Remicade (infliximab) Drug Revenue by Country (2015-2020) (US$ Million) Table 73. Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Country (2015-2020) Table 74. Janssen Corporation Information Table 75. Janssen Description and Business Overview Table 76. Janssen Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 77. Janssen Remicade (infliximab) Drug Product Table 78. Janssen Recent Development Table 79. Hospira Corporation Information Table 80. Hospira Description and Business Overview Table 81. Hospira Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 82. Hospira Product Table 83. Hospira Recent Development Table 84. Celltrion Healthcare Corporation Information Table 85. Celltrion Healthcare Description and Business Overview Table 86. Celltrion Healthcare Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 87. Celltrion Healthcare Product Table 88. Celltrion Healthcare Recent Development Table 89. Epirus Biopharmaceuticals Corporation Information Table 90. Epirus Biopharmaceuticals Description and Business Overview Table 91. Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 92. Epirus Biopharmaceuticals Product Table 93. Epirus Biopharmaceuticals Recent Development Table 94. Samsung Bioepsis Corporation Information Table 95. Samsung Bioepsis Description and Business Overview Table 96. Samsung Bioepsis Remicade (infliximab) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 97. Samsung Bioepsis Product Table 98. Samsung Bioepsis Recent Development Table 99. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 100. Key Challenges Table 101. Market Risks Table 102. Main Points Interviewed from Key Remicade (infliximab) Drug Players Table 103. Remicade (infliximab) Drug Customers List Table 104. Remicade (infliximab) Drug Distributors List Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Remicade (infliximab) Drug Product Picture Figure 2. Global Remicade (infliximab) Drug Sales Market Share by Type in 2020 & 2026 Figure 3. Brands Drugs Product Picture Figure 4. Generic Drugs Product Picture Figure 5. Global Remicade (infliximab) Drug Sales Market Share by Application in 2020 & 2026 Figure 6. Crohn's Disease Figure 7. Pediatric Crohn's Disease Figure 8. Ulcerative Colitis Figure 9. Pediatric Ulcerative Colitis Figure 10. Other Figure 11. Remicade (infliximab) Drug Report Years Considered Figure 12. Global Remicade (infliximab) Drug Market Size 2015-2026 (US$ Million) Figure 13. Global Remicade (infliximab) Drug Sales 2015-2026 (K Units) Figure 14. Global Remicade (infliximab) Drug Market Size Market Share by Region: 2020 Versus 2026 Figure 15. Global Remicade (infliximab) Drug Sales Market Share by Region (2015-2020) Figure 16. Global Remicade (infliximab) Drug Sales Market Share by Region in 2019 Figure 17. Global Remicade (infliximab) Drug Revenue Market Share by Region (2015-2020) Figure 18. Global Remicade (infliximab) Drug Revenue Market Share by Region in 2019 Figure 19. Global Remicade (infliximab) Drug Sales Share by Manufacturer in 2019 Figure 20. The Top 10 and 5 Players Market Share by Remicade (infliximab) Drug Revenue in 2019 Figure 21. Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 22. Global Remicade (infliximab) Drug Sales Market Share by Type (2015-2020) Figure 23. Global Remicade (infliximab) Drug Sales Market Share by Type in 2019 Figure 24. Global Remicade (infliximab) Drug Revenue Market Share by Type (2015-2020) Figure 25. Global Remicade (infliximab) Drug Revenue Market Share by Type in 2019 Figure 26. Global Remicade (infliximab) Drug Market Share by Price Range (2015-2020) Figure 27. Global Remicade (infliximab) Drug Sales Market Share by Application (2015-2020) Figure 28. Global Remicade (infliximab) Drug Sales Market Share by Application in 2019 Figure 29. Global Remicade (infliximab) Drug Revenue Market Share by Application (2015-2020) Figure 30. Global Remicade (infliximab) Drug Revenue Market Share by Application in 2019 Figure 31. United States Remicade (infliximab) Drug Sales Growth Rate 2015-2026 (K Units) Figure 32. United States Remicade (infliximab) Drug Revenue Growth Rate 2015-2026 (US$ Million) Figure 33. United States Remicade (infliximab) Drug Market Share in Global Market 2015-2026 Figure 34. United States 5 and 10 Largest Remicade (infliximab) Drug Players Market Share by Revenue in Remicade (infliximab) Drug in 2019 Figure 35. United States Remicade (infliximab) Drug Revenue Share by Type (2015-2020) Figure 36. United States Remicade (infliximab) Drug Revenue Growth Rate by Type in 2015 & 2019 Figure 37. United States Remicade (infliximab) Drug Revenue Share by Application (2015-2020) Figure 38. United States Remicade (infliximab) Drug Revenue Growth Rate by Application in 2015 & 2019 Figure 39. North America Remicade (infliximab) Drug Sales Growth Rate 2015-2020 (K Units) Figure 40. North America Remicade (infliximab) Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 41. North America Remicade (infliximab) Drug Sales Market Share by Country in 2019 Figure 42. North America Remicade (infliximab) Drug Revenue Market Share by Country in 2019 Figure 43. U.S. Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 44. U.S. Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Canada Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 46. Canada Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Europe Remicade (infliximab) Drug Sales Growth Rate 2015-2020 (K Units) Figure 48. Europe Remicade (infliximab) Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 49. Europe Remicade (infliximab) Drug Sales Market Share by Country in 2019 Figure 50. Europe Remicade (infliximab) Drug Revenue Market Share by Country in 2019 Figure 51. Germany Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 52. Germany Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. France Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 54. France Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. U.K. Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 56. U.K. Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Italy Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 58. Italy Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Russia Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 60. Russia Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Asia Pacific Remicade (infliximab) Drug Sales Growth Rate 2015-2020 (K Units) Figure 62. Asia Pacific Remicade (infliximab) Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 63. Asia Pacific Remicade (infliximab) Drug Sales Market Share by Region in 2019 Figure 64. Asia Pacific Remicade (infliximab) Drug Revenue Market Share by Region in 2019 Figure 65. China Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 66. China Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Japan Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 68. Japan Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. South Korea Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 70. South Korea Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. India Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 72. India Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Australia Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 74. Australia Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Taiwan Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 76. Taiwan Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Indonesia Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 78. Indonesia Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Thailand Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 80. Thailand Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Malaysia Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 82. Malaysia Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Philippines Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 84. Philippines Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Vietnam Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 86. Vietnam Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 87. Latin America Remicade (infliximab) Drug Sales Growth Rate 2015-2020 (K Units) Figure 88. Latin America Remicade (infliximab) Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 89. Latin America Remicade (infliximab) Drug Sales Market Share by Country in 2019 Figure 90. Latin America Remicade (infliximab) Drug Revenue Market Share by Country in 2019 Figure 91. Mexico Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 92. Mexico Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Brazil Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 94. Brazil Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Argentina Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 96. Argentina Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 97. Middle East and Africa Remicade (infliximab) Drug Sales Growth Rate 2015-2020 (K Units) Figure 98. Middle East and Africa Remicade (infliximab) Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 99. Middle East and Africa Remicade (infliximab) Drug Sales Market Share by Country in 2019 Figure 100. Middle East and Africa Remicade (infliximab) Drug Revenue Market Share by Country in 2019 Figure 101. Turkey Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 102. Turkey Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. Saudi Arabia Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 104. Saudi Arabia Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. U.A.E Remicade (infliximab) Drug Sales Growth Rate (2015-2020) (K Units) Figure 106. U.A.E Remicade (infliximab) Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. Porter's Five Forces Analysis Figure 108. Remicade (infliximab) Drug Value Chain Figure 109. Channels of Distribution Figure 110. Distributors Profiles Figure 111. Bottom-up and Top-down Approaches for This Report Figure 112. Data Triangulation Figure 113. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Medical Devices Reports

Portable Dialysis Devices Market Size, Share | Industry Analysis Report, 2026

According to credible estimates, the global portable dialysis devices market is expected to register substantial growth by the year 2026. Advancements in computer, miniaturization, and nanotechnology along with growing inclination towards portable me...

SPECT & SPECT-CT Market | Industry Analysis, Trends, and Forecast to 2025

SPECT and SPECT-CT market is likely to witness lucrative gains over 2020-2025 and reach a valuation of US $1810.9 million by the end of the forecast period. According to the estimates by reliable sources, the global SPECT and SPECT-CT market is anti...

Global Cardiac Stent Market Growth 2021-2026

According to this latest study, the 2020 growth of Cardiac Stent will have significant change from previous year. By the most conservative estimates of global Cardiac Stent market size (most likely outcome) will be a year-over-year revenue growth rat...

Global Ventilator Market Growth 2021-2026

According to this latest study, the 2020 growth of Ventilator will have significant change from previous year. By the most conservative estimates of global Ventilator market size (most likely outcome) will be a year-over-year revenue growth rate of X...

Global ICU Ventilator Market Growth 2021-2026

According to this latest study, the 2020 growth of ICU Ventilator will have significant change from previous year. By the most conservative estimates of global ICU Ventilator market size (most likely outcome) will be a year-over-year revenue growth r...

Other Reports by QY Research

Global Wearable Blood Glucose Monitoring Systems Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Urine Based Glucose Monitoring Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Self Glucose Monitoring Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Remote Patient Monitoring (RPM) System Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Global Non-wearable Blood Glucose Monitoring Systems Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segme...

Publisher: QY Research
Chat with us